BioPharma Dive

JULY 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Merck to buy Verona and its lung drug in $10B deal The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Drug Pricing

STAT

AUGUST 22, 2023

The Food and Drug Administration approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people, STAT tells us. The vaccine, marketed as Abrysvo, previously won approval for adults over the age of 60. Continue to STAT+ to read the full story…

Vaccines

Pharmaceutical Technology

DECEMBER 20, 2022

This downturn in market cap was attributed to a decline in the demand for Covid-19 vaccines and therapies. The growing competition from generic drugs presents challenges for the top 20 players placing pressure on drug prices. billion for Q3, according to GlobalData’s Drugs Database. trillion in Q2 2022 to $3.14

Vaccines

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. Sanders (I-Vt.)

Diabetes

STAT

JULY 6, 2023

Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us.

Drug Pricing

STAT

OCTOBER 8, 2024

Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list , STAT tells us. In the late 1990s, the FDA raised concerns the vaccine lost potency toward the end of its 24-month shelf life.

Compounding

BioPharma Dive

JULY 22, 2025

The more insulin we prescribe, the more diabetes there is,” Makary said. July 02, 2025 Not Just a Patch earns FDA, EU clearance for CGM patches line, expanding diabetes support offe… From Not Just a Patch July 04, 2025 Editors picks Adeline Kon/BioPharma Dive Deep Dive // Emerging biotech Biotech IPOs are the industry’s lifeblood.

Drug Pricing

PharmaShots

MAY 9, 2023

Prevalence of Obesity: Obesity acts as an instigator for other health-related conditions like diabetes, cardiovascular, hypertension, and many more. Due to a surge in such conditions, companies must manufacture drugs related to such conditions.

Pharmaceutical Companies

pharmaphorum

APRIL 27, 2022

The reputation of COVID-19 vaccine makers understandably soared early on, as clinical trials were started and completed in record time, giving hopes to millions of people in lockdown. Among individuals not vaccinated by choice, internet searches ranked as the number one source. Working on a diabetes drug?

Vaccines

Pharmaceutical Technology

MAY 16, 2023

increase in market capitalisation over Q1 2023, fuelled by its robust portfolio of diabetes and obesity treatments – in particular, its line of glucagon-like peptide 1 receptor agonist (GLP-1) Type 2 diabetes drugs Ozempic, Rybelsus and Victoza. Novo Nordisk reported an 18.2%

Diabetes

BioPharma Dive

JULY 23, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Vaccines RFK Jr. In a statement, HHS said Kennedy’s action fulfills “a commitment to restore trust with Americans by removing risk while sustaining access to vaccines.”

Vaccines

BioPharma Dive

JULY 21, 2025

Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. as Scientific Advisor From Receptor.AI Registered in England and Wales. TechTarget, Inc.s

Specialty Pharmacies

BioPharma Dive

JUNE 23, 2025

Cidara will provide detailed results at a future medical meeting and intends to meet with the Food and Drug Administration to discuss the design of a Phase 3 trial. Study success could open the door to an alternative to seasonal influenza vaccines, which some Wall Street analysts view as a multibillion-dollar sales opportunity.

Vaccines

BioPharma Dive

JUNE 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Sponsored The golden era of GLP-1 drugs: How will it impact medicine and society? You can unsubscribe at anytime. Registered in England and Wales. TechTarget, Inc.s

Diabetes

Express Pharma

JANUARY 30, 2025

anti-vaccine stance. The outcome raised concerns about the companys competitive position in the growing obesity and diabetes drug market. per cent decline in market capitalisation in 2024, following its acquisition of Vifor Pharma in August 2022, aimed at diversifying its portfolio of vaccines and blood plasma products.

Vaccines

BioPharma Dive

JUNE 23, 2025

At the FDA, Makary has set stricter approval standards for COVID-19 vaccines, ordered the rapid adoption of a new artifical intelligence tool and rolled out a new program to more quickly review drugs that support U.S. You can unsubscribe at anytime. The turnover is occuring as Makary and his boss HHS Secretary Robert F. Kennedy Jr.

Drug Pricing

BioPharma Dive

JUNE 12, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Pharma’s wins and losses in the budget bill Key pharma reforms are up in the air as Republicans battle over their mammoth legislation that includes significant healthcare spending cuts.

Drug Pricing